BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week High at $1.96

BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $1.96 and last traded at $1.89, with a volume of 55994 shares changing hands. The stock had previously closed at $1.87.

BioRestorative Therapies Stock Up 1.1 %

The stock has a market capitalization of $3.10 billion, a PE ratio of -1.77 and a beta of 102.36. The stock’s 50 day moving average price is $1.54 and its 200-day moving average price is $1.52.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.